The UroGen Medical Affairs website is designed to support US healthcare professionals with access to scientific, non-promotional educational content related to UroGen’s uro-oncology portfolio and areas of research. The site brings together resources on low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) and low-grade upper tract urothelial cancer (LG-UTUC), alongside information on UGN-101, UGN-102, and pipeline assets.
Healthcare professionals can explore downloadable congress materials, including scientific presentations and posters on UGN-101, UGN-102, and pipeline assets from congresses, as well as peer-reviewed publications covering literature relevant to LG-IR-NMIBC and LG-UTUC. The site also provides selected medical information resources for UGN-101 and UGN-102, with information on intravesical treatment with mitomycin, and materials organized by topics such as administration, preparation, safety, storage, handling, and clinical information.
For product-specific information, the site includes access to prescribing information as well as options to submit a medical inquiry or connect with UroGen Medical Affairs. Additional resources include links to the UroGen pipeline, grants, the uTRACT registry, and investigator-initiated studies, helping healthcare professionals find further information on UroGen’s scientific work and ongoing uro-oncology research.
By bringing these resources together in one place, the UroGen Medical Affairs website aims to support scientific exchange and access to medical information, by helping healthcare professionals navigate scientific content by topic, product, or area of interest.